Guenter Billen

USPTO Granted Patents = 11 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

Niedernhaussen, DE (2009 - 2011)
Niedernhausen, DE (2009 - 2013)
Frankfurt-am-Main, DE (2012 - 2020)

Company Filing History:

6 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

Years Active: 2009-2020

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10696633 - Process for the preparation of fexofenadine and of intermediates used therein (2020-06-30),

2. 9067918 - Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide (2015-06-30),

3. 8716481 - Process for the preparation of 6-substituted-1-(2H)-isoquinolinones (2014-05-06),

4. 8546567 - Method for producing 2-(2-aminopyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives (2013-10-01),

5. 8461312 - Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives (2013-06-11),

6. 8236810 - Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV (2012-08-07),

7. 8232395 - Method for producing 2-(2-aminopyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives (2012-07-31),

8. 8053590 - Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives (2011-11-08),

9. 7563888 - Process for the preparation of diphenyl azetidinone derivatives (2009-07-21),

10. 7514578 - Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives (2009-04-07),

11. 7488818 - Method for producing 1,4-diphenyl azetidinone derivatives (2009-02-10),

Title: The Innovative Mind of Guenter Billen

Introduction

Guenter Billen, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, Billen has demonstrated his expertise and innovative spirit in developing new and improved methods for the preparation of vital compounds.

Latest Patents

Guenter Billen's latest patents include a cutting-edge process for the preparation of fexofenadine and its intermediates. This innovative method enhances the production efficiency of this important antihistamine. Additionally, he has developed novel crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid, which are vital for pharmaceutical compositions. These advancements can potentially improve the efficacy and delivery of medications.

Career Highlights

Throughout his career, Guenter Billen has worked with reputable organizations, including Sanofi and Sanofi-Aventis Deutschland GmbH. His experience in these prominent companies has provided him with the resources and collaborative environment to advance his research and patent applications.

Collaborations

Billen has collaborated with notable colleagues, including Wendelin Frick and Joachim Graeser. These partnerships have been instrumental in driving innovative research and propelling his inventions forward in the pharmaceutical domain.

Conclusion

Guenter Billen's contributions to the field of pharmaceuticals through his patents reflect his dedication to innovation and improving drug preparation processes. His work not only showcases his individual brilliance but also emphasizes the importance of collaboration in advancing scientific knowledge and healthcare solutions. As the pharmaceutical industry evolves, inventors like Billen will continue to play a crucial role in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.